GlobeNewswire by notified

Experts call for greater understanding of ‘bedwetting’ as a medical condition

Share
  • Bedwetting, also known as enuresis, is an uncontrollable leakage of urine while asleep1
     
  • Bedwetting is common in children, with approximately 5–10% of 7-year-olds regularly wetting their beds and the problem may persist into teenage and adulthood2
     
  • In most cases, bedwetting is a complex medical condition caused by over-production of urine at night or reduced capacity of the bladder, which can impact a child’s overall self-esteem, emotional well-being and day time functioning1 , 3

SAINT-PREX, Switzerland, May 27, 2019 (GLOBE NEWSWIRE) -- Recent survey findings highlighted there are misconceptions underlying bedwetting, a condition that is under-recognised and misunderstood by society and healthcare professionals.3,4 A frequent misconception of bedwetting is that the cause is psychological, rather than having a multifactorial pathophysiological basis.1 , 4 Furthermore, the survey revealed that not only parents but also health care providers share this misconception and treatment was not necessarily consistent with guidelines.4

“For physicians to effectively treat bedwetting, any existing behavioural issues must be managed as a separate condition,” said Dr. Michal Maternik, Department of Urology, Division of Paediatric Urology, Medical University of Gdansk, Poland. “The survey findings highlight the need for new educational initiatives to optimise the understanding of bedwetting and provision of care amongst the medical community, parents and the public.”

Bedwetting can lead to feelings of shame and low self-esteem, preventing many patients from seeking treatment.3 , 4 According to the new survey, patients and their respected caregivers reported bedwetting to be associated with behavioural difficulties including, ‘sustaining attention’ (28%), ‘maintaining attention at school’ (29%), and sleeping difficulties (21%) resulting in repercussions on school performance.4 These consequences are often prolonged as many parents seek lifestyle changes first and nearly half of them do not seek help in children five years or older.4

“For decades, bedwetting was considered as a simple condition that would resolve spontaneously,” said Professor Serdar Tekgül at the Department of Urology at Hacettepe University, Turkey. “Bedwetting is now regarded as a complex disorder involving several factors such as bladder dysfunction, and the over-production of urine at night”.

The survey was completed by physicians and patients in Alpe-Adria, Italy, Romania, Russia, Serbia and Slovakia on their understanding of the medical condition, its impact on the lives of patients and the prevalence of comorbidities.4

About Bedwetting
Bedwetting, also known as enuresis, is an uncontrollable leakage of urine while asleep in children from aged 5 years.1 In most cases it is caused by over-production of urine at night or reduced capacity of the bladder.2 An inability to wake up can be another cause.2 Bedwetting does not have a psychological cause.1 Bedwetting is a common childhood medical condition, with approximately 5–10% of 7 year-olds regularly wetting their beds and the problem may persist into teenage and adulthood.2

About World Bedwetting Day
World Bedwetting Day was initiated to raise awareness among the public and healthcare professionals that bedwetting is a common medical condition that can and should be treated. World Bedwetting Day 2019 will take place on 28th May 2019 and occurs on the last Tuesday of May each year. The theme is: ‘Time to Take Action’, in recognition that much more can be done to diagnose and treat those children who suffer from bedwetting.

For more information please visit www.worldbedwettingday.com.

About the World Bedwetting Day Steering Committee
The World Bedwetting Day Steering Committee brings together experts from across the globe to support this initiative and consists of the International Children’s Continence Society (ICCS), the European Society of Paediatric Urology (ESPU), the Asia Pacific Association of Paediatric Urology (APAPU), the International Paediatric Nephrology Association (IPNA), the European Society of Paediatric Nephrology (ESPN), the Sociedad Iberoamericana de Urologia Paediatrica (SIUP), the North American Paediatric Urology Societies, ERIC (The Children's Bowel & Bladder Charity) and Bladder & Bowel UK. The initiative is supported by Ferring Pharmaceuticals. 

1 Theunis M et al. Self-Image and Performance in Children with Nocturnal Enuresis. European Urology. 2002; 41:660-667
2 Nevéus T. Nocturnal enuresis—theoretic background and practical guidelines. Pediatr Nephrol. 2011; 26:1207–1214
3 Vande Walle J et al, Practical consensus guidelines for the management of enuresis. Eur J Pediatr 2012;171:971-983
4 Maternik. Understanding of and misconceptions around monosymptomatic nocturnal enuresis: findings from patient and physician surveys. Journal of Pediatric Urology 2018

Contact:
Emma Barrow
Emma.barrow@gcihealth.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8147ae15-92f1-41ed-a13a-b1db5f6df6ec

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

EPH European Property Holdings PLC announces 2023 Year-End Result26.4.2024 23:55:00 CEST | Press release

26 April 2024, Limassol, Cyprus / Ad hoc announcement pursuant to Art. 53 LR BUSINESS HIGHLIGHTS 2023 Despite the challenging market environment, EPH European Property Holdings PLC (“EPH” or the “Company”) maintained operational stability in 2023. This success can be attributed to its established portfolio of high-quality properties in prime locations in Europe, and professional asset management. As a result, EPH once again achieved almost full occupancy throughout its European portfolio, and exceeded own expectations by increasing net rental income by 26 percent compared to the previous year.As of 31 December 2023, EPH’s real estate portfolio consisted of eight core assets (and one parking garage) in outstanding locations in Germany and Vienna, all of which meet high sustainability standards. Seven out of eight office and hotel buildings have already been awarded certificates in DGNB Platinum, DGNB Gold, or LEED Gold.A milestone in the operating business was the completion of the LASS

FRO – Filing of Annual Report26.4.2024 22:36:43 CEST | Press release

Frontline plc (the “Company”) announces the filing of its annual report for the year ended December 31, 2023. The annual report can be downloaded from the Company’s website www.frontlineplc.cy or from the link below. Additionally, shareholders can request a hard copy of our complete audited financial statements free of charge by writing to us at: John Kennedy 8 Iris Building, 7th floor, Flat/Office 740B, 3106, Limassol, Cyprus. or sending an e-mail to ir@frontmgt.no April 26, 2024 Frontline plc Limassol, Cyprus. Questions should be directed to: Lars H. Barstad: Chief Executive Officer, Frontline Management AS +47 23 11 40 00 Inger M. Klemp: Chief Financial Officer, Frontline Management AS +47 23 11 40 00 This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act. Attachments 5493004BCIKYU1YL3H63-2023-12-31-enAnnual Report 2023

Kallelse till årsstämma 2024 i Fingerprint Cards AB (publ)26.4.2024 22:16:32 CEST | Pressemelding

Aktieägarna i Fingerprint Cards AB (publ), org. nr. 556154-2381 (”Bolaget” eller ”Fingerprint”), kallas härmed till årsstämma klockan 15.00 tisdagen den 28 maj 2024 på GT30 (mötesrum ”Bond”), Grev Turegatan 30 i Stockholm. Styrelsen har, i enlighet med Bolagets bolagsordning, beslutat att aktieägarna före årsstämman ska ha möjlighet att utöva sin rösträtt genom poströstning. Aktieägare kan därmed välja att utöva sin rösträtt vid stämman personligen, genom ombud eller genom poströstning. A. Rätt att delta på stämman Aktieägare som önskar delta vid årsstämman ska: vara införd i den av Euroclear Sweden AB förda aktieboken måndagen den 20 maj 2024, och anmäla sin avsikt att delta vid stämman till Bolaget i enlighet med anvisningarna under avsnitt ”B. Anmälan för deltagande personligen eller genom ombud” senast onsdagen den 22 maj 2024, eller avge en poströst i enlighet med anvisningarna under rubriken ”C.Anvisningar för poströstning” senast onsdagen den 22 maj 2024. För att ha rätt att del

Notice to attend the 2024 Annual General Meeting of Fingerprint Cards AB (publ)26.4.2024 22:16:32 CEST | Press release

The shareholders of Fingerprint Cards AB (publ), Corp. Reg. No. 556154-2381 (hereinafter referred to as the “Company” or “Fingerprint”)), are hereby invited to attend the Annual General Meeting (“AGM” or the “Meeting”) to be held at 3:00 p.m. on Tuesday, May 28, 2024, at GT30 (meeting room “Bond”), Grev Turegatan 30 in Stockholm. The Board of Directors has decided, pursuant to the Company’s articles of association, that shareholders shall also have the right to exercise their voting rights by postal voting. Shareholders may therefore choose to exercise their voting rights at the Meeting by attending in person, through a proxy or by postal voting. A. Right to participate in the Meeting In order to participate in the Meeting, a shareholder shall: be registered in the register of shareholders maintained by Euroclear Sweden AB as of Monday, May 20, 2024, and give notice of attendance at the Meeting to the Company in accordance with the instructions set out in the section “B. Notice of atte

Fingerprints announces partially guaranteed rights issue of up to approximately SEK 310 million, agreement on early redemption of its convertible bonds, bridge loan of SEK 60 million and preliminary financial information for Q1 202426.4.2024 22:00:00 CEST | Press release

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL. PLEASE SEE "IMPORTANT INFORMATION" AT THE END OF THIS PRESS RELEASE. The Board of Directors of Fingerprint Cards AB ("Fingerprints" or the "Company") has resolved on a partially guaranteed issue of new shares of series B (“B-shares”) of up to approximately SEK 310 million with preferential rights for its existing shareholders, subject to subsequent approval from the annual general meeting in the Company to be held on 28 May 2024 (the “Rights Issue”). The Rights Issue is subject to subscription undertakings and guarantee commitments in a total amount of up to SEK 275 million. The Board of Directors of Fingerprints has also entered into an agreement with an entity managed by

HiddenA line styled icon from Orion Icon Library.Eye